DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) slid 1.19% to $112.56 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.32% to 6,501.86 and the Dow Jones Industrial Average rising 0.16% to 45,636.90.
This was the stock's second consecutive day of losses.
Gilead Sciences Inc. closed 7.61% below its 52-week high of $121.83, which the company achieved on August 12th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 0.76% to $175.45, Pfizer Inc. $(PFE)$ fell 1.87% to $24.60, and Abbott Laboratories $(ABT)$ fell 0.07% to $131.37.
Trading volume (4.1 M) remained 2.8 million below its 50-day average volume of 6.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
August 28, 2025 16:37 ET (20:37 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.